These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

472 related items for PubMed ID: 29796841

  • 1. Association of hyperhomocysteinemia with genetic variants in key enzymes of homocysteine metabolism and methotrexate toxicity in rheumatoid arthritis patients.
    Chaabane S, Messedi M, Akrout R, Ben Hamad M, Turki M, Marzouk S, Keskes L, Bahloul Z, Rebai A, Ayedi F, Maalej A.
    Inflamm Res; 2018 Aug; 67(8):703-710. PubMed ID: 29796841
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Methylenetetrahydrofolate reductase C677T and A1298C polymorphisms and variations of homocysteine concentrations in patients with Behcet's disease.
    Messedi M, Frigui M, Chaabouni Kh, Turki M, Neifer M, Lahiyani A, Messaouad M, Bahloul Z, Ayedi F, Jamoussi K.
    Gene; 2013 Sep 15; 527(1):306-10. PubMed ID: 23827456
    [Abstract] [Full Text] [Related]

  • 4. Polymorphisms in MTHFR, MS and CBS genes and homocysteine levels in a Pakistani population.
    Yakub M, Moti N, Parveen S, Chaudhry B, Azam I, Iqbal MP.
    PLoS One; 2012 Sep 15; 7(3):e33222. PubMed ID: 22470444
    [Abstract] [Full Text] [Related]

  • 5. The role of vitamin B12 in fasting hyperhomocysteinemia and its interaction with the homozygous C677T mutation of the methylenetetrahydrofolate reductase (MTHFR) gene. A case-control study of patients with early-onset thrombotic events.
    D'Angelo A, Coppola A, Madonna P, Fermo I, Pagano A, Mazzola G, Galli L, Cerbone AM.
    Thromb Haemost; 2000 Apr 15; 83(4):563-70. PubMed ID: 10780318
    [Abstract] [Full Text] [Related]

  • 6. Homocysteine and folate status in methotrexate-treated patients with rheumatoid arthritis.
    van Ede AE, Laan RF, Blom HJ, Boers GH, Haagsma CJ, Thomas CM, De Boo TM, van de Putte LB.
    Rheumatology (Oxford); 2002 Jun 15; 41(6):658-65. PubMed ID: 12048292
    [Abstract] [Full Text] [Related]

  • 7. Thymidylate synthase genetic polymorphism and plasma total homocysteine level in a group of Turkish patients with rheumatoid arthritis: relationship with disease activity and methotrexate toxicity.
    Borman P, Taşbaş Ö, Karabulut H, Tukun A, Yorgancıoğlu R.
    Rev Bras Reumatol; 2015 Jun 15; 55(6):485-92. PubMed ID: 25687398
    [Abstract] [Full Text] [Related]

  • 8. 2756GG genotype of methionine synthase reductase gene is more prevalent in rheumatoid arthritis patients treated with methotrexate and is associated with methotrexate-induced nodulosis.
    Berkun Y, Abou Atta I, Rubinow A, Orbach H, Levartovsky D, Aamar S, Arbel O, Dresner-Pollak R, Friedman G, Ben-Yehuda A.
    J Rheumatol; 2007 Aug 15; 34(8):1664-9. PubMed ID: 17611986
    [Abstract] [Full Text] [Related]

  • 9. Genetic determinants of methotrexate toxicity in rheumatoid arthritis patients: a study of polymorphisms affecting methotrexate transport and folate metabolism.
    Bohanec Grabar P, Logar D, Lestan B, Dolzan V.
    Eur J Clin Pharmacol; 2008 Nov 15; 64(11):1057-68. PubMed ID: 18607581
    [Abstract] [Full Text] [Related]

  • 10. Polymorphisms in the thymidylate synthase and methylenetetrahydrofolate reductase genes and sensitivity to the low-dose methotrexate therapy in patients with rheumatoid arthritis.
    Kumagai K, Hiyama K, Oyama T, Maeda H, Kohno N.
    Int J Mol Med; 2003 May 15; 11(5):593-600. PubMed ID: 12684695
    [Abstract] [Full Text] [Related]

  • 11. Polymorphisms in the methylenetetrahydrofolate reductase and methionine synthase reductase genes and homocysteine levels in Brazilian children.
    Aléssio AC, Annichino-Bizzacchi JM, Bydlowski SP, Eberlin MN, Vellasco AP, Höehr NF.
    Am J Med Genet A; 2004 Jul 30; 128A(3):256-60. PubMed ID: 15216546
    [Abstract] [Full Text] [Related]

  • 12. Methotrexate related adverse effects in patients with rheumatoid arthritis are associated with the A1298C polymorphism of the MTHFR gene.
    Berkun Y, Levartovsky D, Rubinow A, Orbach H, Aamar S, Grenader T, Abou Atta I, Mevorach D, Friedman G, Ben-Yehuda A.
    Ann Rheum Dis; 2004 Oct 30; 63(10):1227-31. PubMed ID: 15361376
    [Abstract] [Full Text] [Related]

  • 13. [Effect of polymorphisms on key enzymes in homocysteine metabolism, on plasma homocysteine level and on coronary artery-disease risk in a Tunisian population].
    Belkahla R, Omezzine A, Kchok K, Rebhi L, Ben Hadj Mbarek I, Rejeb J, Ben Rejeb N, Slimane N, Nabli N, Ben Abdelaziz A, Boughzala E, Bouslama A.
    Ann Cardiol Angeiol (Paris); 2008 Aug 30; 57(4):219-24. PubMed ID: 18620331
    [Abstract] [Full Text] [Related]

  • 14. Polymorphism C776G in the transcobalamin II gene and homocysteine, folate and vitamin B12 concentrations. Association with MTHFR C677T and A1298C and MTRR A66G polymorphisms in healthy children.
    Aléssio AC, Höehr NF, Siqueira LH, Bydlowski SP, Annichino-Bizzacchi JM.
    Thromb Res; 2007 Aug 30; 119(5):571-7. PubMed ID: 16820193
    [Abstract] [Full Text] [Related]

  • 15. Evaluation of the relationship between C677T variants of methylenetetrahydrofolate reductase gene and hyperhomocysteinemia in children receiving antiepileptic drug therapy.
    Vurucu S, Demirkaya E, Kul M, Unay B, Gul D, Akin R, Gokçay E.
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr 01; 32(3):844-8. PubMed ID: 18234410
    [Abstract] [Full Text] [Related]

  • 16. [A clinical study of hyperhomocysteinemia in rheumatological diseases].
    Xu XY, Zhou WH, Xiao CS, Li XF, Wang LY.
    Zhonghua Nei Ke Za Zhi; 2005 Feb 01; 44(2):111-4. PubMed ID: 15840222
    [Abstract] [Full Text] [Related]

  • 17. Homocysteine plasma levels in patients treated with antiepileptic drugs depend on folate and vitamin B12 serum levels, but not on genetic variants of homocysteine metabolism.
    Semmler A, Moskau-Hartmann S, Stoffel-Wagner B, Elger C, Linnebank M.
    Clin Chem Lab Med; 2013 Mar 01; 51(3):665-9. PubMed ID: 23382314
    [Abstract] [Full Text] [Related]

  • 18. Interactions of 5'-UTR thymidylate synthase polymorphism with 677C → T methylene tetrahydrofolate reductase and 66A → G methyltetrahydrofolate homocysteine methyl-transferase reductase polymorphisms determine susceptibility to coronary artery disease.
    Vijaya Lakshmi SV, Naushad SM, Rupasree Y, Seshagiri Rao D, Kutala VK.
    J Atheroscler Thromb; 2011 Mar 01; 18(1):56-64. PubMed ID: 20962453
    [Abstract] [Full Text] [Related]

  • 19. Hyperhomocysteinemia is related to residual glomerular filtration and folate, but not to methylenetetrahydrofolate-reductase and methionine synthase polymorphisms, in supplemented end-stage renal disease patients undergoing hemodialysis.
    Anwar W, Guéant JL, Abdelmouttaleb I, Adjalla C, Gérard P, Lemoel G, Erraess N, Moutabarrek A, Namour F.
    Clin Chem Lab Med; 2001 Aug 01; 39(8):747-52. PubMed ID: 11592445
    [Abstract] [Full Text] [Related]

  • 20. [Hyperhomocysteinemia and deep-vein thrombosis].
    Qiu L, Yan SK, Song YH.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Dec 01; 25(6):706-9. PubMed ID: 14714317
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.